Pasithea Therapeutics Corp.
Developing innovative therapeutics for CNS disorders (ALS, MS) and RASopathies.
KTTA | NDAQ
Overview
Corporate Details
- ISIN(s):
- US70261F1030
- LEI:
- Country:
- United States of America
- Address:
- 1111 LINCOLN ROAD, SUITE 500, 33139 MIAMI BEACH
- Website:
- https://www.pasithea.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Pasithea Therapeutics Corp. is a clinical-stage biotechnology company focused on the discovery, research, and development of innovative treatments for central nervous system (CNS) disorders and RASopathies. The company is dedicated to creating new therapeutics for complex neurological and psychiatric conditions with significant unmet medical needs. Its primary research pipeline targets treatments for Neurofibromatosis type 1 (NF1), Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and schizophrenia.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
Automate Your Workflow. Get a real-time feed of all Pasithea Therapeutics Corp. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pasithea Therapeutics Corp.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pasithea Therapeutics Corp. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
